Cargando…

Prostatic Artery Embolization as a Treatment Option for Symptomatic Benign Prostatic Hyperplasia: Results from the Prospective Follow-Up Study in Lithuania

Background: The endovascular treatment of symptomatic benign prostate hypertrophy (BPH) by prostatic artery embolization (PAE) is one of the new treatments proposed. PAE is a minimally invasive alternative that has been shown to successfully treat lower urinary tract symptoms in BPH patients by caus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jankauskas, Tautvydas, Buržinskis, Edgaras, Kaupas, Rytis Stasys, Basevičius, Algidas, Jievaltas, Mindaugas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10608601/ https://www.ncbi.nlm.nih.gov/pubmed/37893589 http://dx.doi.org/10.3390/medicina59101871

Ejemplares similares

Impact of the 2014 International Society of Urological Pathology Grading System on Concept of High-Risk Prostate Cancer: Comparison of Long-Term Oncological Outcomes in Patients Undergoing Radical Prostatectomy
por: Milonas, Daimantas, et al.
Publicado: (2019)

Importance of prostate volume and urinary flow rate in prediction of bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia
por: Trumbeckas, Darius, et al.
Publicado: (2011)

Single-centre experience in the endovascular treatment of acute superior mesenteric artery occlusion: an observational analytical 3-year study
por: Kaupas, Dominykas, et al.
Publicado: (2022)

Clinical predictive factors in prostatic artery embolization for symptomatic benign prostatic hyperplasia: a comprehensive review
por: Sun, Fei, et al.
Publicado: (2020)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

Bipolar Transurethral Enucleation of the Prostate: Is it a size-independent endoscopic treatment option for symptomatic benign prostatic hyperplasia?
por: Bebi, Carolina, et al.
Publicado: (2021)

Prostate embolization in the treatment of benign prostatic hyperplasia: what’s the point?
por: Nunes, Thiago Franchi, et al.
Publicado: (2021)

Assessment of radiographers’ competences from the perspectives of radiographers and radiologists: a cross-sectional survey in Lithuania
por: Vanckavičienė, Aurika, et al.
Publicado: (2017)

Transurethral ethanol ablation for symptomatic benign prostatic hyperplasia
por: Gautam, Gagan, et al.
Publicado: (2007)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
por: Radwan, Ahmed, et al.
Publicado: (2020)

Benign Prostatic Hyperplasia
Publicado: (2015)

Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
por: Zhang, Jin Long, et al.
Publicado: (2018)

Prostatic Artery Embolization for the Treatment of Benign Prostate Hyperplasia: Initial Experience From Bahrain
por: Hamed Ibrahim, Wael, et al.
Publicado: (2022)

Safety and efficacy of prostatic artery embolization for large benign prostatic hyperplasia in elderly patients
por: Xu, Chen, et al.
Publicado: (2021)

Outcome of surgery in locally advanced pT3a prostate cancer
por: Milonas, Daimantas, et al.
Publicado: (2011)

Evaluation of intermittent tamsulosin in treating symptomatic patients with benign prostatic hyperplasia
por: Soliman, Mohamed G., et al.
Publicado: (2023)

Various treatment options for benign prostatic hyperplasia: A current update
por: Shrivastava, Alankar, et al.
Publicado: (2012)

3D printed model to assist endovascular prostate artery embolization for benign prostatic hyperplasia
por: Dalla, Shiv, et al.
Publicado: (2022)

Radiation dose of prostatic artery embolization for benign prostatic hyperplasia: A protocol for systematic review
por: Liu, Jinglei, et al.
Publicado: (2022)

Transurethral resection of the prostate versus prostatic artery embolization in the treatment of benign prostatic hyperplasia: a meta-analysis
por: Jiang, Yu-Li, et al.
Publicado: (2019)

Bacteriology of Urine Specimens Obtained from Men with Symptomatic Benign Prostatic Hyperplasia
por: Agbugui, Jude Orumuah, et al.
Publicado: (2016)

Bipolar transurethral enucleation of prostate versus photoselective vaporization for symptomatic benign prostatic hyperplasia (>70 ml)
por: Mu, Xiao-Nan, et al.
Publicado: (2017)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Prostatic Artery Embolization as a Primary Treatment for Benign Prostatic Hyperplasia: Preliminary Results in Two Patients
por: Carnevale, Francisco Cesar, et al.
Publicado: (2009)

Comparison of Nonspherical Polyvinyl Alcohol Particles and Microspheres for Prostatic Arterial Embolization in Patients with Benign Prostatic Hyperplasia
por: Hwang, Jin Ho, et al.
Publicado: (2017)

Clinical Outcomes of Prostatic Artery Embolization in Patients with Benign Prostatic Hyperplasia: A Prospective Clinical Study
por: Dogan, Kazım, et al.
Publicado: (2022)

Influence of benign prostatic hyperplasia patterns detected with MRI on the clinical outcome after prostatic artery embolization
por: Boschheidgen, Matthias, et al.
Publicado: (2023)

Holmium Laser Enucleation of the Prostate is Effective in the Treatment of Symptomatic Benign Prostatic Hyperplasia of Any Size Including a Small Prostate
por: Lee, Min Ho, et al.
Publicado: (2014)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Systematic review and meta-analysis of Transurethral Needle Ablation in symptomatic Benign Prostatic Hyperplasia
por: Bouza, Carmen, et al.
Publicado: (2006)

Does angiotensin-converting enzyme polymorphism have association with symptomatic benign prostatic hyperplasia?
por: Bid, Hemant Kumar, et al.
Publicado: (2010)

Efficacy and Tolerability of Tamsulosin 0.4 mg in Patients with Symptomatic Benign Prostatic Hyperplasia
por: Chung, Jae-Wook, et al.
Publicado: (2011)

Activation of innate anti-viral immune response genes in symptomatic benign prostatic hyperplasia
por: Madigan, Allison A., et al.
Publicado: (2012)

Symptomatic comparison in efficacy on patients with benign prostatic hyperplasia treated with two therapeutic approaches
por: Li, Shao, et al.
Publicado: (2010)

Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia
por: Blair, Hannah A.
Publicado: (2022)

Evaluating the potential impact of COVID-19 passports in Lithuania
por: Stankūnas, Mindaugas, et al.
Publicado: (2022)

Radiological Findings of Prostatic Arterial Anatomy for Prostatic Arterial Embolization: Preliminary Study in 55 Chinese Patients with Benign Prostatic Hyperplasia
por: Zhang, Guodong, et al.
Publicado: (2015)

Modern imaging and image-guided treatments of the prostate gland: MR and ablation for cancer and prostatic artery embolization for benign prostatic hyperplasia
por: Dias, João Lopes, et al.
Publicado: (2019)

An Updated Meta-Analysis of the Efficacy and Safety of Prostatic Artery Embolization vs. Transurethral Resection of the Prostate in the Treatment of Benign Prostatic Hyperplasia
por: Xu, Zhunan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_f7010p1c2jg6nn2lb8q3j6rtbo